Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
Sheng Xiao(Brigham and Women's Hospital), Nir Yosef(Broad Institute), Jianfei Yang(GlaxoSmithKline (United States)), Yonghui Wang(GlaxoSmithKline (China)), Ling Zhou(GlaxoSmithKline (China)), Chen Zhu(Brigham and Women's Hospital), Chuan Wu(Brigham and Women's Hospital), Erkan Baloglu(GlaxoSmithKline (United States)), Darby Schmidt(GlaxoSmithKline (United States)), Radha Ramesh(GlaxoSmithKline (United States)), Mercedes Lobera(GlaxoSmithKline (United States)), Mark S. Sundrud(GlaxoSmithKline (United States)), Pei‐Yun Tsai(Technische Universität Dresden), Zhijun Xiang(GlaxoSmithKline (China)), Jinsong Wang(GlaxoSmithKline (China)), Yan Xu(GlaxoSmithKline (China)), Xichen Lin(GlaxoSmithKline (China)), Karsten Kretschmer(Technische Universität Dresden), Peter B. Rahl(Whitehead Institute for Biomedical Research), Richard A. Young(Whitehead Institute for Biomedical Research), Zhong Zhong(GlaxoSmithKline (China)), David A. Hafler(Yale University), Aviv Regev(Broad Institute), Shomir Ghosh(GlaxoSmithKline (United States)), Alexander Marson(University of California, San Francisco), Vijay Kuchroo(Brigham and Women's Hospital)
Cited by 276Open Access
Abstract
Related Papers
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Claire L. Langrish, Yi Chen, Wendy M. Blumenschein et al.|The Journal of Experimental Medicine|2005|4k